Interplay of synaptic changes, neuroinflammation and beta-amyloid in cognitively normal subjects with varying risk of late-onset Alzheimer's disease (ASIC-E4)

Description of the granted funding

Early brain changes in unsymptomatic phase of Alzheimer's disease (AD) need to be characterized better, to enable successful disease modifying treatments in the future. The presence of epsilon 4-allele of Apolipoprotein E (APOE4) gene is the most important genetic risk factor for the more common late-onset AD. This study uses molecular neuroimaging and fluid-based biomarker methods to uncover the interplay of synaptic loss, neuroinflammation, amyloid deposition and structural brain changes in cognitively normal elderly volunteers with high, medium or low risk for AD due to different APOE genotype. Results provide much needed information about the presence and relationship of early biomarkers in preclinical AD. In addition, the study validates methods that could be utilized in early detection of AD pathologies, screening of study subjects and investigating effects of novel disease modifying compounds targeted against synaptic restoration and neuroinflammation in the future.
Show more

Starting year

2021

End year

2024

Granted funding

Anniina Snellman Orcid -palvelun logo
228 610 €

Funder

Research Council of Finland

Funding instrument

Postdoctoral Researcher

Other information

Funding decision number

341059

Fields of science

Neurosciences

Research fields

Neurotiede

Identified topics

brain, neuroscience